广东省紧密型医联体药事管理工作的调研分析

朱晓丹; 陈孝; 曹伟灵; 曾援; 卢佐京; 李学钧; 陈文瑛

doi:10.6039/j.issn.1001-0408.2024.04.02

您当前的位置：

首页 >

文章列表页 >

广东省紧密型医联体药事管理工作的调研分析

药事管理 | 更新时间：2024-02-23

- 广东省紧密型医联体药事管理工作的调研分析
- Investigation and analysis of pharmaceutical management in compact medical consortium of Guangdong province
- 中国药房 2024年35卷第4期页码：390-394
- 作者机构：
  
  1.南方医科大学第三附属医院药学部，广州　510630
  2.中山大学附属第一医院药学部，广州　510080
  3.深圳市罗湖区人民医院，广东深圳　518020
  4.南雄市人民医院药学部，广东韶关　512400
  5.阳西总医院，广东阳江　529800
  6.广东省卫生健康委员会，广州　510060
- 作者简介：
  
  硕士研究生。研究方向：药事管理。E-mail：r993zxd@163.com
  主任药师，博士。研究方向：临床药学。E-mail：chenwenying2016@163.com
- 基金信息：
  
  中国药学会医院药学专委会医院药学科研专项(CPA-Z05-ZC-2021-002)
- DOI：10.6039/j.issn.1001-0408.2024.04.02
  中图分类号： R95
- 纸质出版日期：2024-02-29，
  
  收稿日期：2023-07-14，
  
  修回日期：2024-01-27，
扫描看全文
朱晓丹,陈孝,曹伟灵等.广东省紧密型医联体药事管理工作的调研分析 ^Δ[J].中国药房,2024,35(04):390-394.

ZHU Xiaodan,CHEN Xiao,CAO Weiling,et al.Investigation and analysis of pharmaceutical management in compact medical consortium of Guangdong province[J].ZHONGGUO YAOFANG,2024,35(04):390-394.
朱晓丹,陈孝,曹伟灵等.广东省紧密型医联体药事管理工作的调研分析 ^Δ[J].中国药房,2024,35(04):390-394. DOI： 10.6039/j.issn.1001-0408.2024.04.02.

ZHU Xiaodan,CHEN Xiao,CAO Weiling,et al.Investigation and analysis of pharmaceutical management in compact medical consortium of Guangdong province[J].ZHONGGUO YAOFANG,2024,35(04):390-394. DOI： 10.6039/j.issn.1001-0408.2024.04.02.

摘要

目的

调查广东省紧密型医联体的药事管理工作现状，为推动广东省医联体高质量建设和可持续发展提供决策依据。

方法

自行设计调查问卷，抽取广东省50家紧密型医联体为研究对象，由总院药学部负责人作答，调查内容包括医联体基本规模、医联体总药师聘任情况、医联体内药事管理与药学服务同质化执行情况、推动同质化的难点、希望获得的省级支持等，并对调查结果进行描述性统计分析。

结果

共回收问卷50份，有效回收率为100%。医联体总院药学部负责人有16人（占32.00%）被聘任为总药师。37家医联体（占74.00%）已建立医联体内药品供应保障体系，35家医联体（占70.00%）已开展医联体内药事管理统筹工作，23家医联体（占46.00%）已建立临床用药指导体系，25家医联体（占50.00%）已建立双向交流机制，仅8家医联体（占16.00%）有拓展药学服务新模式。目前推动医联体内药事管理与药学服务同质化的难点主要在于“各成员单位的管理水平差距较大”“药学人员缺乏、水平参差不齐”“政策支持与落实不足”3个方面。大部分医联体希望相关部门通过举办专项培训班或开展专项督导的方式推进药事工作向同质化发展。

结论

目前广东省紧密型医联体在落实总药师制度、药事管理与药学服务同质化建设方面取得了初步成效，但仍需提高医联体中总药师聘任的覆盖率，将药事管理同质化工作落实到位，并加快药学服务同质化进程。

Abstract

OBJECTIVE

To investigate the current situation of pharmaceutical management in compact medical consortium of Guangdong province， and to provide decision-making basis for promoting the high-quality construction and sustainable development of the provincial medical consortium.

METHODS

A self-designed questionnaire was used to select 50 compact medical consortiums in Guangdong province. The survey was answered by the heads of the pharmacy department of the general hospitals. The survey covered the basic scale of the consortium， the appointment of chief pharmacists， the implementation of pharmaceutical management and pharmaceutical care homogenization within the consortium， the difficulties in promoting the homogenization， and the expected provincial support. Descriptive statistical analysis was performed on the survey results.

RESULTS

A total of 50 questionnaires were collected， and the effective recovery rate was 100%. There were 16 chief pharmacists （32.00%） in charge of the pharmacy department of the general hospital in the medical consortium. Thirty-seven medical consortiums （74.00%） had established a drug supply support system within the consortium， 35 medical consortiums （70.00%） had carried out pharmaceutical management and coordination work within the medical consortium， 23 medical consortiums （46.00%） had established a clinical medication guidance system， 25 medical consortiums （50.00%） had established a bidirectional communication mechanism， and only 8 medical consortiums （16.00%） had developed new models of pharmaceutical care. At present， the difficulties in promoting the homogenization of pharmaceutical management and pharmaceutical care within the medical consortium were mainly found in three aspects： the wide gap in management level of each member unit， the lack and uneven level of pharmaceutical personnel， and insufficient policy support and implementation. Most medical consortiums hoped that relevant departments could promote the homogenization of pharmaceutical work by holding special training courses or special supervision.

CONCLUSIONS

At present， the compact medical consortium in Guangdong province has achieved initial results in the implementation of the chief pharmacist system， the homogenization of pharmaceutical management and pharmaceutical care. However， it is still necessary to improve the coverage of chief pharmacist appointments in the medical consortium， implement the homogenization of pharmaceutical management， and accelerate the homogenization process of pharmaceutical care.

关键词

医联体药事管理药学服务同质化总药师制度

Keywords

pharmacy administrationpharmaceutical carehomogenizationchief pharmacist system

references

汪洪滨. 完善县域医共体三大机制[J]. 中国卫生，2022（10）：65.

WANG H B. Perfecting the three mechanisms of county medical community[J]. China Health，2022（10）：65.

皇甫天然，何炳洪，邓艳辉，等. 医联体总药师制度促进基层医疗机构合理用药的实践与探索[J]. 中国药房，2022，33（6）：753-757.

HUANGFU T R，HE B H，DENG Y H，et al. Practice and exploration of improving the rational use of drugs in primary medical institutions by the general pharmacist system of the medical consortium[J]. China Pharm，2022，33（6）：753-757.

石爱平，恽祥惠，吕建峰，等. 县域医共体内药学服务同质化阶段性探索实践[J]. 中国药业，2022，31（22）：15-18.

SHI A P，YUN X H，LYU J F，et al. Phased exploration and practice of homogenization of pharmaceutical care in the county medical community[J]. China Pharm，2022，31（22）：15-18.

PENM J，LI Y，ZHAI S D，et al. The impact of clinical pharmacy services in China on the quality use of medicines：a systematic review in context of China’s current healthcare reform[J]. Health Policy Plan，2014，29（7）：849-872.

WAN C C，HUANG Y K，CHEN L，et al. The influence of non-clinical pharmacists’ understanding of and attitudes towards pharmaceutical care on their willingness to serve as clinical pharmacists in China[J]. BMC Health Serv Res，2022，22（1）：484.

YANG R M，LI Q，HAYAT K，et al. Views of pharmacists and government representatives toward the pilot chief pharmacist system in Chinese hospitals：a multicenter exploratory qualitative study[J]. Front Public Health，2022，10：895649.

王瑞麟，满春霞，李思聪，等. 医疗卫生体制改革背景下我国药师队伍发展现状的调查分析[J]. 中国医院药学杂志，2021，41（11）：1091-1096，1113.

WANG R L，MAN C X，LI S C，et al. Development status of Chinese pharmacist team under the background of healthcare reform[J]. Chin J Hosp Pharm，2021，41（11）：1091-1096，1113.

王静林，胡琪，曾芳，等. 湖北省494家医疗机构临床药学发展及临床药师培训现状调研[J]. 中国医院药学杂志，2021，41（24）：2582-2585.

WANG J L，HU Q，ZENG F，et al. Development of clinical pharmacy and clinical pharmacist training at 494 medical institutions in Hubei Province[J]. Chin J Hosp Pharm，2021，41（24）：2582-2585.

揭映楣，黄紫彤，陈敏生. 广东某县域医共体分级诊疗建设效果研究[J]. 卫生软科学，2021，35（5）：24-27.

JIE Y M，HUANG Z T，CHEN M S. Study on the effect of county medical community hierarchical diagnosis and treatment construction in Guangdong Province[J]. Soft Sci Health，2021，35（5）：24-27.

裴婕，闫岩，赵志霞，等. 我国总药师制度发展现状及启示[J]. 世界临床药物，2021，42（2）：155-158.

PEI J，YAN Y，ZHAO Z X，et al. The development status of chief pharmacist system in China[J]. World Clin Drugs，2021，42（2）：155-158.

陈锷锐，杨遥东，钱辉，等. 县域医共体药事垂直化管理的探索和成效[J]. 中国农村卫生事业管理，2021，41（12）：889-892，897.

CHEN E R，YANG Y D，QIAN H，et al. Exploration and effect of vertical management of pharmaceutical affairs in county medical community[J]. Chin Rural Health Serv Adm，2021，41（12）：889-892，897.

郑彩云，黄奕祥，王欣. 广东省县域医共体建设现状分析与运行效果评价：基于二阶聚类和秩和比法[J]. 现代预防医学，2022，49（22）：4132-4138.

ZHENG C Y，HUANG Y X，WANG X. Current situation analysis and operation effect evaluation of county medical community in Guangdong province：based on two-step cluster and rank-sum ratio method[J]. Mod Prev Med，2022，49（22）：4132-4138.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

医联体同质化肿瘤药学门诊的建立与实践效果评价 ^Δ